Arch Therapeutics, Inc.

ARTHOTCHealthcare

$0.00

+$0.00(+0.00%)

Market Cap$444

P/E Ratio—

52W High$1.567

52W Low$0.0001

Avg Volume2K

Open$0.20

Beta4.03

Overview

Arch Therapeutics, Inc. (ARTH) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ARTH · as of Dec 28, 2022

Latest filing snapshot

-2-20.00%vs prior year

Arch Therapeutics, Inc. (ARTH) employee data is sourced from the annual SEC 10-K filing. As of 2022, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2022-09-30·Full-time · Global

Total Employees

Change (1Y)

-2

Growth % (1Y)

-20.00%

Revenue / Employee

$9.5K

Net Income / Employee

$-872.9K

Market Cap

$0M

ARTH Employee Count

2012 – 2022 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2022-12-28	2022-09-30	8	-2	-20.00%
2021-12-17	2021-09-30	10	+3	+42.86%
2020-12-11	2020-09-30	7	-1	-12.50%
2019-11-19	2019-09-30	8	+0	+0.00%
2018-12-18	2018-09-30	8	+0	+0.00%
2017-11-15	2017-09-30	8	+2	+33.33%
2016-12-05	2016-09-30	6	+2	+50.00%
2015-12-11	2015-09-30	4	-1	-20.00%
2014-12-12	2014-09-30	5	+3	+150.00%
2013-12-27	2013-09-30	2	+2	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

MICRD

Micron Solutions, Inc.

82$0M

IMVIQ

IMV Inc.

63$0M

ALNAQ

Allena Pharmaceuticals, Inc.

12$0M

ARTH

Arch Therapeutics, Inc.YOU

8$0M

MDKM

MDEChem, Inc.

1$0M

ACGJ

ACI Global Corporation

N/A$0M

BLEVF

Beleave Inc.

N/A$0M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ARTH peer comparison

About ARTH employees

ARTH Employees · Headcount

Arch Therapeutics, Inc. (ARTH) employee data is sourced from the annual SEC 10-K filing. As of 2022, Arch Therapeutics, Inc. had 8 full-time employees globally. Full-time employees only. Global consolidated headcount.

Arch Therapeutics, Inc. employs 8 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $9,466, reflecting the company's operational efficiency.

Arch Therapeutics, Inc.'s workforce decreased by 2 (20.00%) in 2022 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Arch Therapeutics, Inc.'s revenue per employee of $9,466 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

ARTH Employees · 5 questions

As of the latest SEC 10-K filing (2022), Arch Therapeutics, Inc. had 8 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Arch Therapeutics, Inc. employee counthow many employees does Arch Therapeutics, Inc. haveARTH total employees 2022

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2022-12-28